OTC Artificial Tears - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511250445

Publication Date:

November 19, 2024

Pages:

120

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for OTC Artificial Tears was estimated to be worth US$ 2922 million in 2023 and is forecast to a readjusted size of US$ 5119.7 million by 2030 with a CAGR of 8.3% during the forecast period 2024-2030
OTC Artificial Tears are lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
Report Scope
This report aims to provide a comprehensive presentation of the global market for OTC Artificial Tears, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of OTC Artificial Tears by region & country, by Type, and by Application.
The OTC Artificial Tears market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Artificial Tears.
麻豆原创 Segmentation
By Company
OcuSoft
Santen Pharmaceutical Co. Ltd
Johnson and Johnson
Bausch and Lamb
Alcon
Similasan Corporation
Akorn, Inc.
Sun Pharmaceutical Industries Limited
AbbVie, Inc.
Ursapharm Arzneimittel GmbH
Segment by Type:
Preservative Based
Non-preservative Based
Segment by Application
Hospital Pharmacies
Drug Stores
Online
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of OTC Artificial Tears manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of OTC Artificial Tears in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of OTC Artificial Tears in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 OTC Artificial Tears Product Introduction
1.2 Global OTC Artificial Tears 麻豆原创 Size Forecast
1.2.1 Global OTC Artificial Tears Sales Value (2019-2030)
1.2.2 Global OTC Artificial Tears Sales Volume (2019-2030)
1.2.3 Global OTC Artificial Tears Sales Price (2019-2030)
1.3 OTC Artificial Tears 麻豆原创 Trends & Drivers
1.3.1 OTC Artificial Tears Industry Trends
1.3.2 OTC Artificial Tears 麻豆原创 Drivers & Opportunity
1.3.3 OTC Artificial Tears 麻豆原创 Challenges
1.3.4 OTC Artificial Tears 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global OTC Artificial Tears Players Revenue Ranking (2023)
2.2 Global OTC Artificial Tears Revenue by Company (2019-2024)
2.3 Global OTC Artificial Tears Players Sales Volume Ranking (2023)
2.4 Global OTC Artificial Tears Sales Volume by Company Players (2019-2024)
2.5 Global OTC Artificial Tears Average Price by Company (2019-2024)
2.6 Key Manufacturers OTC Artificial Tears Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers OTC Artificial Tears Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of OTC Artificial Tears
2.9 OTC Artificial Tears 麻豆原创 Competitive Analysis
2.9.1 OTC Artificial Tears 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by OTC Artificial Tears Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Artificial Tears as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Preservative Based
3.1.2 Non-preservative Based
3.2 Global OTC Artificial Tears Sales Value by Type
3.2.1 Global OTC Artificial Tears Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global OTC Artificial Tears Sales Value, by Type (2019-2030)
3.2.3 Global OTC Artificial Tears Sales Value, by Type (%) (2019-2030)
3.3 Global OTC Artificial Tears Sales Volume by Type
3.3.1 Global OTC Artificial Tears Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global OTC Artificial Tears Sales Volume, by Type (2019-2030)
3.3.3 Global OTC Artificial Tears Sales Volume, by Type (%) (2019-2030)
3.4 Global OTC Artificial Tears Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Drug Stores
4.1.3 Online
4.2 Global OTC Artificial Tears Sales Value by Application
4.2.1 Global OTC Artificial Tears Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global OTC Artificial Tears Sales Value, by Application (2019-2030)
4.2.3 Global OTC Artificial Tears Sales Value, by Application (%) (2019-2030)
4.3 Global OTC Artificial Tears Sales Volume by Application
4.3.1 Global OTC Artificial Tears Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global OTC Artificial Tears Sales Volume, by Application (2019-2030)
4.3.3 Global OTC Artificial Tears Sales Volume, by Application (%) (2019-2030)
4.4 Global OTC Artificial Tears Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global OTC Artificial Tears Sales Value by Region
5.1.1 Global OTC Artificial Tears Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global OTC Artificial Tears Sales Value by Region (2019-2024)
5.1.3 Global OTC Artificial Tears Sales Value by Region (2025-2030)
5.1.4 Global OTC Artificial Tears Sales Value by Region (%), (2019-2030)
5.2 Global OTC Artificial Tears Sales Volume by Region
5.2.1 Global OTC Artificial Tears Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global OTC Artificial Tears Sales Volume by Region (2019-2024)
5.2.3 Global OTC Artificial Tears Sales Volume by Region (2025-2030)
5.2.4 Global OTC Artificial Tears Sales Volume by Region (%), (2019-2030)
5.3 Global OTC Artificial Tears Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America OTC Artificial Tears Sales Value, 2019-2030
5.4.2 North America OTC Artificial Tears Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe OTC Artificial Tears Sales Value, 2019-2030
5.5.2 Europe OTC Artificial Tears Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific OTC Artificial Tears Sales Value, 2019-2030
5.6.2 Asia Pacific OTC Artificial Tears Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America OTC Artificial Tears Sales Value, 2019-2030
5.7.2 South America OTC Artificial Tears Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa OTC Artificial Tears Sales Value, 2019-2030
5.8.2 Middle East & Africa OTC Artificial Tears Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions OTC Artificial Tears Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions OTC Artificial Tears Sales Value
6.2.1 Key Countries/Regions OTC Artificial Tears Sales Value, 2019-2030
6.2.2 Key Countries/Regions OTC Artificial Tears Sales Volume, 2019-2030
6.3 United States
6.3.1 United States OTC Artificial Tears Sales Value, 2019-2030
6.3.2 United States OTC Artificial Tears Sales Value by Type (%), 2023 VS 2030
6.3.3 United States OTC Artificial Tears Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe OTC Artificial Tears Sales Value, 2019-2030
6.4.2 Europe OTC Artificial Tears Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe OTC Artificial Tears Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China OTC Artificial Tears Sales Value, 2019-2030
6.5.2 China OTC Artificial Tears Sales Value by Type (%), 2023 VS 2030
6.5.3 China OTC Artificial Tears Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan OTC Artificial Tears Sales Value, 2019-2030
6.6.2 Japan OTC Artificial Tears Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan OTC Artificial Tears Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea OTC Artificial Tears Sales Value, 2019-2030
6.7.2 South Korea OTC Artificial Tears Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea OTC Artificial Tears Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia OTC Artificial Tears Sales Value, 2019-2030
6.8.2 Southeast Asia OTC Artificial Tears Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia OTC Artificial Tears Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India OTC Artificial Tears Sales Value, 2019-2030
6.9.2 India OTC Artificial Tears Sales Value by Type (%), 2023 VS 2030
6.9.3 India OTC Artificial Tears Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 OcuSoft
7.1.1 OcuSoft Company Information
7.1.2 OcuSoft Introduction and Business Overview
7.1.3 OcuSoft OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.1.4 OcuSoft OTC Artificial Tears Product Offerings
7.1.5 OcuSoft Recent Development
7.2 Santen Pharmaceutical Co. Ltd
7.2.1 Santen Pharmaceutical Co. Ltd Company Information
7.2.2 Santen Pharmaceutical Co. Ltd Introduction and Business Overview
7.2.3 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Santen Pharmaceutical Co. Ltd OTC Artificial Tears Product Offerings
7.2.5 Santen Pharmaceutical Co. Ltd Recent Development
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Company Information
7.3.2 Johnson and Johnson Introduction and Business Overview
7.3.3 Johnson and Johnson OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Johnson and Johnson OTC Artificial Tears Product Offerings
7.3.5 Johnson and Johnson Recent Development
7.4 Bausch and Lamb
7.4.1 Bausch and Lamb Company Information
7.4.2 Bausch and Lamb Introduction and Business Overview
7.4.3 Bausch and Lamb OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bausch and Lamb OTC Artificial Tears Product Offerings
7.4.5 Bausch and Lamb Recent Development
7.5 Alcon
7.5.1 Alcon Company Information
7.5.2 Alcon Introduction and Business Overview
7.5.3 Alcon OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Alcon OTC Artificial Tears Product Offerings
7.5.5 Alcon Recent Development
7.6 Similasan Corporation
7.6.1 Similasan Corporation Company Information
7.6.2 Similasan Corporation Introduction and Business Overview
7.6.3 Similasan Corporation OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Similasan Corporation OTC Artificial Tears Product Offerings
7.6.5 Similasan Corporation Recent Development
7.7 Akorn, Inc.
7.7.1 Akorn, Inc. Company Information
7.7.2 Akorn, Inc. Introduction and Business Overview
7.7.3 Akorn, Inc. OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Akorn, Inc. OTC Artificial Tears Product Offerings
7.7.5 Akorn, Inc. Recent Development
7.8 Sun Pharmaceutical Industries Limited
7.8.1 Sun Pharmaceutical Industries Limited Company Information
7.8.2 Sun Pharmaceutical Industries Limited Introduction and Business Overview
7.8.3 Sun Pharmaceutical Industries Limited OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sun Pharmaceutical Industries Limited OTC Artificial Tears Product Offerings
7.8.5 Sun Pharmaceutical Industries Limited Recent Development
7.9 AbbVie, Inc.
7.9.1 AbbVie, Inc. Company Information
7.9.2 AbbVie, Inc. Introduction and Business Overview
7.9.3 AbbVie, Inc. OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.9.4 AbbVie, Inc. OTC Artificial Tears Product Offerings
7.9.5 AbbVie, Inc. Recent Development
7.10 Ursapharm Arzneimittel GmbH
7.10.1 Ursapharm Arzneimittel GmbH Company Information
7.10.2 Ursapharm Arzneimittel GmbH Introduction and Business Overview
7.10.3 Ursapharm Arzneimittel GmbH OTC Artificial Tears Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Ursapharm Arzneimittel GmbH OTC Artificial Tears Product Offerings
7.10.5 Ursapharm Arzneimittel GmbH Recent Development
8 Industry Chain Analysis
8.1 OTC Artificial Tears Industrial Chain
8.2 OTC Artificial Tears Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 OTC Artificial Tears Sales Model
8.5.2 Sales Channel
8.5.3 OTC Artificial Tears Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

OcuSoft
Santen Pharmaceutical Co. Ltd
Johnson and Johnson
Bausch and Lamb
Alcon
Similasan Corporation
Akorn, Inc.
Sun Pharmaceutical Industries Limited
AbbVie, Inc.
Ursapharm Arzneimittel GmbH

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.